You are here
BCR DIAGNOSTICS, INC.
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: Yes
Woman Owned: No
Award Charts
Award Listing
-
Ultrasensitive Detection of Hepatitis Viruses by Immunoassay Amplification
Amount: $145,637.00DESCRIPTION (provided by applicant): This proposal responds to the action plan for combating the Silent Epidemic of Viral Hepatitis recently launched by the National Institutes of Health by focusing ...
SBIRPhase I2013Department of Health and Human Services National Institutes of Health -
Engineered Spores as Fluorogenic Biological Indicators for Sterility Testing
Amount: $699,007.00DESCRIPTION (provided by applicant): BCR Diagnostics, Inc. (BCR) has recently developed and patented a technology platform for engineering fluorogenic functionality into living Bacillus spores. Fluoro ...
SBIRPhase II2008Department of Health and Human Services National Institutes of Health -
Engineered Spores as Fluorogenic Biological Indicators for Sterility Testing
Amount: $99,930.00DESCRIPTION (provided by applicant): BCR Diagnostics, Inc. (BCR) has recently developed and patented a technology platform for engineering fluorogenic functionality into living Bacil ...
SBIRPhase I2007Department of Health and Human Services National Institutes of Health -
LOW-COST BIOSENSOR FOR REAL-TIME DIAGNOSIS OF BACTEREMIA
Amount: $137,221.00DESCRIPTION (provided by applicant): BCR Diagnostics, Inc. (BCR) proposes to study the feasibility of applying its low-cost biosensor technology to detecting bacteremia in real-time (i.e., less than ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health -
REAL TIME DETECTION OF BACTERIA IN PLATELET CONCENTRATES
Amount: $739,219.00DESCRIPTION (provided by applicant): Bacterial contamination of blood products is currently a major problem in transfusion medicine and a leading cause of transfusion-related deaths. Platelets are pa ...
SBIRPhase II2003Department of Health and Human Services National Institutes of Health -
REAL-TIME DETECTION OF BACTERIA IN PLATELET CONCENTRATES
Amount: $136,210.00DESCRIPTION (Provided by applicant): BCR Diagnostics, Inc. (BCR) proposes to demonstrate the feasibility of adapting its LEXSAS (Label-free Exponential Signal-Amplification System) technology for real ...
SBIRPhase I2002Department of Health and Human Services National Institutes of Health -
Test for Occult Micrometastases in Primary Breast Cancer
Amount: $62,336.00We will develop and validate a new assay system to replace existing immunocytochemicalassays for detecting occult micrometastases in bone marrow of patients with primary breast cancer.This assay would ...
SBIRPhase I1994Department of Health and Human Services